|
Real-time Estimate
Cboe BZX
15:57:39 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 2.285 USD | -3.99% |
|
+11.89% | +9.24% |
| 10-26 | Acumen Pharmaceuticals, Inc., Q3 2026 Earnings Call, Oct 26, 2026 | |
| 10-26 | Acumen Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 172M 154M 142M 129M 241M 16.39B 245M 1.7B 677M 8.58B 646M 632M 27.17B | P/E 2026 * |
-1.65x | P/E 2027 * | -1.59x |
|---|---|---|---|---|---|
| Enterprise Value | -107M -95.63M -88.22M -79.83M -149M -10.17B -152M -1.05B -420M -5.32B -401M -392M -16.85B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
93.21% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ABOS | Delayed | |
CBOE
| ABOS | Real-time |
Last Transcript: Acumen Pharmaceuticals, Inc.
| 1 day | -2.10% | ||
| 1 week | +14.32% | ||
| Current month | +6.08% | ||
| 1 month | +4.90% | ||
| 3 months | +11.61% | ||
| 6 months | +0.64% | ||
| Current year | +11.61% |
| 1 week | 1.9 |  | 2.52 |
| 1 month | 1.62 | | 2.52 |
| Current year | 1.62 | | 3.6 |
| 1 year | 1.5 | | 3.6 |
| 3 years | 0.86 | | 5.09 |
| 5 years | 0.86 | | 15.12 |
| 10 years | 0.86 | | 26.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 56 | 2014-11-30 |
Jim Doherty
PSD | President | 58 | 2024-01-31 |
Matthew Zuga
DFI | Director of Finance/CFO | 60 | 2021-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel O'Connell
BRD | Director/Board Member | 56 | 2006-03-31 |
Jeffrey Ives
BRD | Director/Board Member | 75 | 2014-04-30 |
Sean Stalfort
CHM | Chairman | 56 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Free | Director | 88,750 | 0.1229% | ||
| 6/3/26 | Free | Director | 88,750 | 0.1229% | ||
| 6/3/26 | Free | Director | 88,750 | 0.1229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.10% | +14.32% | +4.20% | +6.80% | 172M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -2.00% | -1.57% | +25.77% | +54.64% | 45.99B | |
| -1.06% | -3.39% | +17.30% | +97.90% | 42.45B | |
| -0.36% | +0.44% | +224.92% | +927.36% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.77% | +5.16% | +47.24% | +146.72% | 39.27B | |
| Weighted average by Cap. | -0.36% | +3.14% | +49.09% | +159.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -106M -95.2M -87.83M -79.48M -149M -10.12B -151M -1.05B -418M -5.3B -399M -390M -16.78B | -127M -113M -105M -94.65M -177M -12.05B -180M -1.25B -498M -6.31B -475M -465M -19.98B |
| Net Debt | -279M -250M -230M -209M -390M -26.56B -396M -2.75B -1.1B -13.9B -1.05B -1.02B -44.02B | -376M -337M -311M -281M -526M -35.8B -534M -3.71B -1.48B -18.73B -1.41B -1.38B -59.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | US$2.305 | -3.15% | 659,015 |
| 26-10-28 | US$2.380 | +5.31% | 1,407,894 |
| 26-10-27 | US$2.260 | -0.44% | 1,797,777 |
| 26-10-26 | US$2.270 | +14.65% | 1,649,956 |
| 26-10-23 | US$1.980 | -3.88% | 541,794 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABOS Stock
Select your edition
All financial news and data tailored to specific country editions
